Saturday 17 October 2026 Export VRDN’s income statement to Excel — free account

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.8 million, up 23,359.9% from fiscal 2024. In the quarter to June 2026, revenue grew 278.7%, EPS fell 5.00%, free cash flow fell 41.4% and total debt rose 1,064.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.03 0.53 −2.71%

Follow VRDN

Alert me

Market cap: $2.2B
P/E: 0.0×
Fwd P/E: −4.1×
Dividend yield: —
F-score: 3/9
Altman Z: 6.69
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(72.53%)	(63.87%)	(78.43%)	(86.93%)
Piotroski F-Score Full definition →		3	3	2	4
ROA Full definition →		(44.77%)	(41.73%)	(49.74%)	(46.08%)
ROIC Full definition →		(622.21%)	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(57.81%)	(41.54%)	(49.12%)	(37.93%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	384.87
Free Cash Flow per Share Full definition →		(3.99)	(3.26)	(2.97)	(3.11)
Free Cash Flow Full definition →		(326.34)	(276.89)	(303.82)	(335.04)
Capital Expenditures Full definition →		(0.37)	(0.49)	(0.43)	(1.70)
Other line items
Cash ROIC Full definition →		(32.16%)	(16.81%)	(20.97%)	(17.77%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	1.89
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		454.42%	478.38%	479.04%	456.47%
Selling, General and Administrative Expense of Revenue Full definition →		109.09%	134.53%	164.83%	213.21%
Share Based Compensation of Revenue Full definition →		58.33%	62.53%	66.94%	75.38%
Interest Coverage Full definition →		(155.65)	(73.44)	(49.07)	(25.89)
Operating CF/Net income Full definition →		1.08	0.81	0.84	0.86
Depreciation/Fixed assets Full definition →		(6.89)	(5.13)	(5.16)	(2.07)
Capex/Depreciation Full definition →		0.05	0.08	0.07	0.30
Revenue per Share Full definition →		0.87	0.84	0.69	0.66
Operating CF per Share Full definition →		(3.99)	(3.26)	(2.97)	(3.09)
Capex per Share Full definition →		0.00	(0.01)	0.00	(0.02)
Capex to Sales Full definition →		0.01	0.01	0.01	0.02

Fold the line items

Columns are period end dates

Stockrow Weekly